American Society of Hematology

Fig. 1.

$Fig. 1. Injection of unfractionated B6 or B6-cdd surface Ig−CD3+ T cells together with B6 bone marrow–induced weight loss in BALB/c recipients. / BALB/c recipients (5 per group) were prepared with 8.5-Gy TBI at 1 day before transplantation; 5 × 106 B6 TCD–bone marrow cells were injected intravenously together with T cells from B6 or B6-cdd donors. ∗, no donor T cells; ▴, 0.5 × 106 B6 T cells; ■, 5.0 × 106 B6-cdd T cells; ▵, 0.5 × 106 B6-cdd T cells.$

Injection of unfractionated B6 or B6-cdd surface Ig⁻CD3⁺ T cells together with B6 bone marrow–induced weight loss in BALB/c recipients.

BALB/c recipients (5 per group) were prepared with 8.5-Gy TBI at 1 day before transplantation; 5 × 10⁶ B6 TCD–bone marrow cells were injected intravenously together with T cells from B6 or B6-cdd donors. ∗, no donor T cells; ▴, 0.5 × 10⁶ B6 T cells; ■, 5.0 × 10⁶ B6-cdd T cells; ▵, 0.5 × 10⁶ B6-cdd T cells.

This Feature Is Available To Subscribers Only